Your browser doesn't support javascript.
loading
Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha.
Kurosawa, Saiko; Yamaguchi, Hiroki; Yamaguchi, Takuhiro; Fukunaga, Keiko; Yui, Shunsuke; Wakita, Satoshi; Kanamori, Heiwa; Usuki, Kensuke; Uoshima, Nobuhiko; Yanada, Masamitsu; Shono, Katsuhiro; Ueki, Toshimitsu; Mizuno, Ishikazu; Yano, Shingo; Takeuchi, Jin; Kanda, Junya; Okamura, Hiroshi; Inamoto, Yoshihiro; Inokuchi, Koiti; Fukuda, Takahiro.
Afiliação
  • Kurosawa S; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. Electronic address: skurosaw@ncc.go.jp.
  • Yamaguchi H; Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Yamaguchi T; Division of Biostatistics, Tohoku University Hospital, Sendai, Japan.
  • Fukunaga K; Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Yui S; Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Wakita S; Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Uoshima N; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Yanada M; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Shono K; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Ueki T; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Mizuno I; Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
  • Yano S; Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Takeuchi J; Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Kanda J; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Okamura H; Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Inokuchi K; Division of Hematology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Biol Blood Marrow Transplant ; 22(6): 1125-1132, 2016 06.
Article em En | MEDLINE | ID: mdl-27040395

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Técnicas de Apoio para a Decisão / Transplante de Células-Tronco Hematopoéticas / Análise Citogenética / Quimioterapia de Consolidação / Mutação Tipo de estudo: Etiology_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Técnicas de Apoio para a Decisão / Transplante de Células-Tronco Hematopoéticas / Análise Citogenética / Quimioterapia de Consolidação / Mutação Tipo de estudo: Etiology_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article